Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People's Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers. Genex Pharmaceutical, Inc. was founded in 2003 and is headquartered in Tianjin City, the People's Republic of China.
Stock data | 2024 | Change |
---|---|---|
Price | $0.0001 | N/A |
Market Cap | $0 | N/A |
Shares Outstanding | 0 | N/A |
Employees | 86.00 | N/A |